Clinical Trials Logo

Clinical Trial Summary

Characterization of the influence of pregnenolone vs. placebo on subjective distress and autonomic functioning during cognitive-behavioral exposure therapy in patients with obsessive-compulsive disorder.


Clinical Trial Description

Main out-come parameters:

Inter-session habituation as per SUD (100 mm VAS), Y-BOCS

Secondary out-come parameter:

HF/LF of HRV, Salivary epinephrine ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01949753
Study type Interventional
Source Universitätsklinikum Hamburg-Eppendorf
Contact Michael Kellner, MD, PhD
Email kellner@uke.uni-hamburg.de
Status Recruiting
Phase Phase 2
Start date September 2013
Completion date December 2018

See also
  Status Clinical Trial Phase
Completed NCT02267629 - Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder Phase 2
Recruiting NCT04042038 - Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder N/A
Completed NCT02867449 - Metacognitive Therapy for Obsessive-Compulsive Disorder N/A
Completed NCT01368510 - Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder N/A
Not yet recruiting NCT05422469 - OCD Biomarker Survey Employing sEEG and Stimulation: The OBSESS Trial N/A
Active, not recruiting NCT03300947 - Psilocybin for Treatment of Obsessive Compulsive Disorder Phase 1
Recruiting NCT02773082 - Reclaimâ„¢ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD) N/A
Not yet recruiting NCT06360991 - DBS for Treatment-resistant Obsessive-compulsive Disorder N/A
Completed NCT03605316 - Deep Electrical Neuromodulation in Obsessive-compulsive Disorder